内科理论与实践2024，Vol.19Issue(5)：337-341,5.DOI:10.16138/j.1673-6087.2024.05.10
结直肠癌预后生物标志物研究进展
Research progress on prognostic biomarkers for colorectal cancer
王虹晓 1苏琪莹 1阎骅1
作者信息
- 1. 上海交通大学医学院附属瑞金医院全科医学科,上海 200025
- 折叠
摘要
Abstract
Colorectal cancer(CRC)is one of the most common malignant tumors of digestive system in the world.Epidemiological statistics showed that the global incidence of CRC ranked third among all cancer types and its mortality rate ranked second in 2020,while the reasons for the increased incidence are still not clear.At present,it is believed that the occurrence of CRC is a multi-factor and multi-step chronic process.Because the onset of CRC is insidious and the early detection rate is low,most patients are diagnosed in the middle and late stage as symptoms develop,which leads to poor prognosis.The average 5-year survival rate of CRC in China was 56.9%,which was the lowest among surrounding Asia-Pacific countries.CRC has become a huge threat to the life and health of Chinese citizens.Therefore,further understanding of prognosis biomarkers of CRC are important in promoting individualized treatment and improving the survival rate and quality of life in CRC patients.This article reviews the research progress on prognostic biomarkers for CRC to provide some inspiration for future treatment of CRC.关键词
结直肠癌/预后/生物标志物/监测Key words
Colorectal cancer/Prognosis/Biomarkers/Monitoring分类
医药卫生引用本文复制引用
王虹晓,苏琪莹,阎骅..结直肠癌预后生物标志物研究进展[J].内科理论与实践,2024,19(5):337-341,5.
